Nationwide study shows BNT162b2 mRNA vaccine is effective

For teens, getting access to speech pathology services depends on where you live
25 February 2021
New coronavirus variant surging in California
25 February 2021

Nationwide study shows BNT162b2 mRNA vaccine is effective

The BNT162b2 mRNA vaccine is effective for COVID-19-related outcomes, including hospitalization, severe illness, and death, in a nationwide, mass vaccination setting, according to a study published online Feb. 24 in the New England Journal of Medicine.

Comments are closed.